Adjuvant medial versus entire supraclavicular lymph node irradiation in high-risk early breast cancer (SUCLANODE): a protocol for a multicenter, randomized, open-label, phase 3 trial

被引：0
|
作者：
Li Zhang
Xin Mei
Zhigang Hu
Bo Yu
Chaoyang Zhang
Yong Li
Kaitai Liu
Xuejun Ma
Jinli Ma
Xingxing Chen
Jin Meng
Wei Shi
Xiaofang Wang
Miao Mo
Zhimin Shao
Zhen Zhang
Xiaoli Yu
Xiaomao Guo
Zhaozhi Yang
机构：
[1] Fudan University Shanghai Cancer Center,Department of Radiation Oncology
[2] Fudan University,Department of Oncology, Shanghai Medical College
[3] Shanghai Key Laboratory of Radiation Oncology,Department of Radiation Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine
[4] University of Science and Technology of China,Department of Radiotherapy
[5] the Affiliated Jiangyin Hospital of Nantong University,Department of Radiation Oncology
[6] The First Hospital of Quanzhou Affiliated to Fujian Medical University,Department of Oncology
[7] Guizhou Provincial People’s Hospital,Department of Radiation Oncology
[8] The Affiliated Lihuili Hospital of Ningbo University,Department of Cancer Prevention & Clinical Statistics Center
[9] Fudan University Shanghai Cancer Center,Department of Breast Surgery
[10] Fudan University Shanghai Cancer Center,Key Laboratory of Breast Cancer in Shanghai
[11] Fudan University Shanghai Cancer Center,Department of Medical Oncology
[12] Kashgar Prefecture Second People ’ s Hospital,undefined
[13] Xinjiang Uyghur Autonomous Region,undefined
来源：
BMC Cancer | / 24卷
关键词：
Breast cancer; Supraclavicular nodal irradiation; Target volume; Survival outcome; Toxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Adjuvant medial versus entire supraclavicular lymph node irradiation in high-risk early breast cancer (SUCLANODE): a protocol for a multicenter, randomized, open-label, phase 3 trial
    Zhang, Li
    Mei, Xin
    Hu, Zhigang
    Yu, Bo
    Zhang, Chaoyang
    Li, Yong
    Liu, Kaitai
    Ma, Xuejun
    Ma, Jinli
    Chen, Xingxing
    Meng, Jin
    Shi, Wei
    Wang, Xiaofang
    Mo, Miao
    Shao, Zhimin
    Zhang, Zhen
    Yu, Xiaoli
    Guo, Xiaomao
    Yang, Zhaozhi
    BMC CANCER, 2024, 24 (01)
  • [2] Entire Versus Medial Supraclavicular Nodal Irradiation for Patients With High-Risk Node-Positive Breast Cancer
    Zhang, Li
    Liu, Jun
    Ma, Jinli
    Mei, Xin
    Chen, Xingxing
    Mo, Miao
    Wang, Xiaofang
    Meng, Jin
    Shi, Wei
    Bazan, Jose G.
    Shao, Zhimin
    Zhang, Zhen
    Yu, Xiaoli
    Guo, Xiaomao
    Yang, Zhaozhi
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (01): : 120 - 129
  • [3] Early versus conventional adjuvant chemotherapy in stage III colon cancer: A multicenter, randomized, open-label, phase 3 trial
    Park, Soo Yeun
    Kim, So Hyun
    Lee, Kyung Ha
    Song, Seung Ho
    Kim, Hye Jin
    Kim, Jong Gwang
    Kang, Byung Woog
    Baek, Seong Kyu
    Jeong, Woon Kyung
    Bae, Sung Uk
    Lee, In Kyu
    Lee, Yoon Suk
    Son, Gyung Mo
    Bae, Ki Beom
    Kim, Ji Yeon
    Park, Jun Seok
    Choi, Gyu-Seog
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Entire vs. Medial Supraclavicular Nodal Irradiation for Patients with High-Risk Node-Positive Breast Cancer
    Zhang, L.
    Liu, J.
    Ma, J.
    Mei, X.
    Chen, X.
    Meng, J.
    Shi, W.
    Bazan, J. G., Jr.
    Yu, X.
    Guo, X.
    Yang, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E8 - E8
  • [5] mFOLFIRINOX versus mFOLFOX 6 as adjuvant treatment for high-risk stage III colon cancer (FROST trial): Study protocol for an open label, multicenter, randomized, phase II study.
    Lee, Kyung-ha
    Kim, Ji Yeon
    Yang, In Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : TPS230 - TPS230
  • [6] Adjuvant PD-1 blockade with camrelizumab in high-risk locoregionally advanced nasopharyngeal carcinoma (DIPPER): A multicenter, open-label, phase 3, randomized controlled trial
    Ma, Jun
    Sun, Ying
    Liang, Ye-Lin
    Shen, Liangfang
    Hu, Weihan
    Hu, Guangyuan
    Xie, Fangyun
    Huang, Ying
    Zou, Guorong
    Zhang, Ning
    Chen, Chuanben
    Chen, Xiaozhong
    Zhu, Xiaodong
    Yuan, Yawei
    Yang, Kunyu
    Jin, Feng
    Hong, Shu-Bin
    Zhao, Hongyun
    Li, Ji-Bin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL) : LBA6000 - LBA6000
  • [7] IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer
    Qi, Wei-Xiang
    Cao, Lu
    Zheng, Siyue
    Xu, Cheng
    Cai, Rong
    Xu, Haoping
    Cai, Gang
    Chen, Jiayi
    BMC CANCER, 2022, 22 (01)
  • [8] IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer
    Wei-Xiang Qi
    Lu Cao
    Siyue Zheng
    Cheng Xu
    Rong Cai
    Haoping Xu
    Gang Cai
    Jiayi Chen
    BMC Cancer, 22
  • [9] Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China A Multicenter, Open-Label, Randomized Clinical Trial
    Zhang, Junji
    Zhao, Yuqian
    Dai, Yi
    Dang, Le
    Ma, Li
    Yang, Chunxia
    Li, Yang
    Kong, Linghua
    Wei, Lihui
    Zhang, Shulan
    Liu, Jihong
    Xi, Minrong
    Chen, Long
    Duan, Xianzhi
    Xiao, Qing
    Abulizi, Guzhalinuer
    Zhang, Guonan
    Hong, Ying
    Gao, Xiaohong
    Zhou, Qi
    Xie, Xing
    Li, Li
    Niyazi, Mayinuer
    Zhang, Zhifen
    Tuo, Jiyu
    Ding, Yiling
    Si, Manfei
    Chen, Fei
    Song, Li
    Qiao, Youlin
    Lang, Jinghe
    JAMA ONCOLOGY, 2021, 7 (02) : 263 - 270
  • [10] HYPofractionated Adjuvant RadioTherapy in 1 versus 2 weeks in high-risk patients with breast cancer (HYPART): a non-inferiority, open-label, phase III randomised trial
    Budhi Singh Yadav
    Divya Dahiya
    P. Kannan
    Shikha Goyal
    Ishita Laroiya
    Santhosh Irrinki
    Ngangom Robert Singh
    Reena Sharma
    Trials, 25
12345